[Ultravist - drug of choice for radioopaque studies in children with renal disfunction].
The nonionic radioopaque ultravist and the high-molar radioopaque verograffin were studied for their effects on the blood osmotic status of children with lower renal concentrating function. A total of 36 children aged 8 months to 12 years who had pyelonephritis, hydronephrosis and renal injury at their acute stage were studied angiographically under general anesthesia. The radioopaque was injected in a mean dose of 2 ml/kg for 2-3 sec. Ultravist was found to have a less osmotic action on the blood osmotic status than did verograffin. The changes in the detectable major blood osmotic parameters: sodium, potassium, glucose, urea, creatine were less pronounced. Plasma osmolality was moderately increased with ultravist and much higher than its normal values with verograffin at min 1 after its administration and at hour 2 of the study. Ultravist is preferable as a radiopaque used in children with decreased renal concentrating function.
Lazarev
V V
VV
Poliaev
Iu A
IuA
Vodolazov
Iu A
IuA
Nikanorov
A Iu
AIu
D000208:Acute Disease; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media; D003974:Diatrizoate Meglumine; D006801:Humans; D006869:Hydronephrosis / Q000097:blood / Q000000981:diagnostic imaging*; D007223:Infant; D007472:Iohexol / Q000031:analogs & derivatives*; D007668:Kidney / Q000000981:diagnostic imaging* / Q000293:injuries; D009994:Osmolar Concentration; D011704:Pyelonephritis / Q000097:blood / Q000000981:diagnostic imaging*; D011859:Radiography
D003287:Contrast Media; D003974:Diatrizoate Meglumine; D007472:Iohexol; C038192:iopromide